Search / Trial NCT06615349

DigiPall; a Randomized Controlled Trial of Digital Patient Reported Outcome and Biomarker Monitoring in Palliative Care

Launched by DAVID BLUM · Sep 23, 2024

Trial Information

Current as of October 09, 2024

Not yet recruiting

Keywords

Palliative Care Chatbot Wearable Pro Ms Rehospitalisation Mobile Health

Description

The aim of this study is to test the effect of a remote symptom and digital biomarker monitoring system on unplanned hospital readmissions, quality of life and sense of security in advanced cancer patients and patients with severe illnesses in palliative care. Patients with cancer or other life-threatening illnesses are often burdened with pain and other distressing symptoms. Palliative care is an approach to prevent and relief suffering by means of early identification, assessment and treatment of these symptoms with the overall aim to improve quality of life of patients. Palliative care...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Patients with established diagnosis of a metastatic cancer/severe illness with limited life expectancy receiving palliative care services
  • * Estimated life expectancy \<24 months (physician's guess)/ \>3 months
  • * Karnofsky Index ≥ 50% / ECOG≤ 2
  • * Aged \>18 years
  • * Owns and uses a smartphone
  • * Give written informed consent
  • Exclusion Criteria:
  • * Patients under curative treatment
  • * Relevant cognitive impairment

About David Blum

David Blum is a distinguished clinical trial sponsor with extensive experience in the design, management, and execution of clinical research studies. Committed to advancing medical science and improving patient outcomes, Mr. Blum collaborates with leading healthcare professionals and institutions to facilitate innovative trials across various therapeutic areas. His strategic approach emphasizes rigorous adherence to regulatory standards, ethical considerations, and data integrity, ensuring that each study contributes valuable insights to the medical community. With a strong focus on fostering partnerships and enhancing participant engagement, David Blum is dedicated to driving progress in clinical research and transforming healthcare.

Locations

Zürich, Zh, Switzerland

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0